Roscosmos praises contribution of US astronaut John Glenn to world cosmonauticsScience & Space December 09, 18:19
Russian Sports Ministry urges investigation into facts stated in McLaren reportSport December 09, 18:13
WADA says RUSADA must demonstrate 'independence from outside interference'Sport December 09, 18:03
Russian PM says Nord Stream-2 project benefits all participantsRussian Politics & Diplomacy December 09, 18:00
Russian premier says Rosneft stake sale is 'largest deal' in 2016Business & Economy December 09, 17:38
IPC says full findings of McLaren report unprecedented, astonishingSport December 09, 17:05
General Staff: Syrian army takes control of 93% of Aleppo’s territoryMilitary & Defense December 09, 17:04
Sakhalin Energy becomes most environmentally responsible oil and gas company in RussiaBusiness & Economy December 09, 16:55
Russian android robot Fedor to acquire self-learning abilitiesScience & Space December 09, 16:43
MOSCOW, June 2. /TASS/. A team of Russian scientists have developed an approach for a method testing for pregnant women with a condition called preeclampsia, the Moscow Institute of Physics and Technology (MIPT) said on Thursday.
The scientists from MIPT, the V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology, the Emanuel Institute for Biochemical Physics, and the Talrose Institute for Energy Problems of Chemical Physics have found potential biomarkers in the urine of pregnant women.
"We were able to confirm a number of markers previously proposed by our colleagues abroad, and also identify some new ones. What is important is that this non-invasive method has proven effective - it can be used as a basis to develop a clinical method," said the assistant manager of the MIPT’s Laboratory of Ionic and Molecular Physics, Alexey Kononikhin.
Preeclampsia is a multisystem disorder that occurs in the second half of pregnancy and is characterized by high blood pressure and proteinuria (a significant increase in the normal level of protein in the urine). Women with the condition suffer headaches, swelling, fainting, and other unpleasant and often dangerous symptoms. Ultimately, preeclampsia puts the health and life of an expectant mother and her baby at serious risk. The symptoms of the condition are ambiguous, so doctors rarely diagnose preeclampsia.
One of the main symptoms of preeclampsia is a marked increase in protein concentration (from the normal 0.03 g/l to the critical 0.3 g/l and above). The scientists wondered whether peptides (pieces of proteins) that are produced by women with preeclampsia could carry information about the disease. This approach is very much in line with the current focus on non-invasive testing, i.e. analyzing available biomaterials such as urine, saliva, or exhaled air.
To identify potential peptide biomarkers, the researchers compared samples of three groups of ten women from the Research Center for Obstetrics, Gynecology and Perinatology: women with a normal pregnancy, and with mild and severe preeclampsia. Following the experiments, 35 peptide biomarkers of preeclampsia were identified.
In the future, this urine-based diagnostic method will enable specialists to detect the disease in its early stages. A paper detailing the results has been published in the Journal of Proteomics.